Regulation of IGF-I mRNA by GH: putative functions for class 1 and 2 message

被引:22
作者
O'Sullivan, DC [1 ]
Szestak, TAM [1 ]
Pell, JM [1 ]
机构
[1] Babraham Inst, Cambridge CB2 4AT, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2002年 / 283卷 / 02期
关键词
liver; transcription; alternative splicing; sheep; growth;
D O I
10.1152/ajpendo.00016.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study investigated mechanisms regulating hepatic insulin-like growth factor (IGF)-I class 1 and 2 mRNA levels. Lambs were treated with growth hormone (GH) either as an acute, single dose or over a longer term. Total hepatic unspliced, pre-mRNA levels increased after the single dose of GH but were attenuated after 8 days of GH, with exon 1- and 2-derived pre-mRNA levels displaying coordinate responses. Surprisingly, changes in total spliced, mature mRNA levels did not reflect those for pre-mRNA, instead being augmented after 8 days of GH. GH also induced a differential increase in the ratio of mature class 2-to-class 1 IGF-I mRNA; therefore, this must be predominantly via posttranscriptional mechanisms. Increases in the ratio of class 2- to-class 1 mRNA were observed in polysomal vs. total RNA preparations derived from GH-treated but not control lambs, indicating an increased proportion of class 2 transcripts engaged in translation. Our findings indicate that GH may stabilize mature class 2 transcripts or destabilize mature class 1 transcripts and that class 2 mRNA may have a greater translational potential. The following two main functions of hepatic class 2 IGF-I mRNA are suggested: an efficient "monitor" of GH status via providing a rapid negative feedback mechanism and a coordinator of endocrine-regulated tissue growth.
引用
收藏
页码:E251 / E258
页数:8
相关论文
共 49 条
[31]   Nucleocytoplasmic transport: The soluble phase [J].
Mattaj, IW ;
Englmeier, L .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :265-306
[32]   mRNA stability in eukaryotes [J].
Mitchell, P ;
Tollervey, D .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (02) :193-198
[33]  
Nielsen J, 1999, MOL CELL BIOL, V19, P1262
[34]   DIFFERENTIAL REGULATION OF TRANSCRIPTION INITIATION FROM INSULIN-LIKE GROWTH FACTOR-I (IGF-I) LEADER EXONS AND OF TISSUE IGF-I EXPRESSION IN RESPONSE TO CHANGED GROWTH-HORMONE AND NUTRITIONAL-STATUS IN SHEEP [J].
PELL, JM ;
SAUNDERS, JC ;
GILMOUR, RS .
ENDOCRINOLOGY, 1993, 132 (04) :1797-1807
[35]  
PELL JM, 1990, BR J NUTR, V63, P341
[36]   Once versus twice daily injections of growth hormone in children with idiopathic short stature [J].
Phillip, M ;
Hershkovitz, E ;
Belotserkovsky, O ;
Leiberman, E ;
Limoni, Y ;
Zadik, Z .
ACTA PAEDIATRICA, 1998, 87 (05) :518-520
[37]   IGF-I IS REQUIRED FOR NORMAL EMBRYONIC GROWTH IN MICE [J].
POWELLBRAXTON, L ;
HOLLINGSHEAD, P ;
WARBURTON, C ;
DOWD, M ;
PITTSMEEK, S ;
DALTON, D ;
GILLETT, N ;
STEWART, TA .
GENES & DEVELOPMENT, 1993, 7 (12B) :2609-2617
[38]   Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions [J].
Rajaram, S ;
Baylink, DJ ;
Mohan, S .
ENDOCRINE REVIEWS, 1997, 18 (06) :801-831
[39]   Protein transport via amino-terminal targeting sequences: Common themes in diverse systems [J].
Rusch, SL ;
Kendall, DA .
MOLECULAR MEMBRANE BIOLOGY, 1995, 12 (04) :295-307
[40]   TISSUE-SPECIFIC TRANSCRIPTION START SITE USAGE IN THE LEADER EXONS OF THE RAT INSULIN-LIKE GROWTH FACTOR-I GENE - EVIDENCE FOR DIFFERENTIAL REGULATION IN THE DEVELOPING KIDNEY [J].
SHEMER, J ;
ADAMO, ML ;
ROBERTS, CT ;
LEROITH, D .
ENDOCRINOLOGY, 1992, 131 (06) :2793-2799